Study Summary
This trial will test whether sending a reminder about the flu vaccine to doctors will increase the number of people who get vaccinated.
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 1 Secondary · Reporting Duration: 2 months
Trial Safety
Safety Progress
Trial Design
2 Treatment Groups
Usual Care
1 of 2
Alert Iteration
1 of 2
Active Control
4000 Total Participants · 2 Treatment Groups
Primary Treatment: Usual Care · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age Any Age · All Participants · 1 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:- Austrian, Jonathan, Felicia Mendoza, Adam Szerencsy, Lucille Fenelon, Leora I Horwitz, Simon Jones, Masha Kuznetsova, and Devin M Mann. 2021. “Applying A/B Testing to Clinical Decision Support: Rapid Randomized Controlled Trials”. Journal of Medical Internet Research. JMIR Publications Inc.. doi:10.2196/16651.
- 2018. "Optimizing the Influenza Clinical Decision Support Tool". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03415425.
Frequently Asked Questions
What is the uppermost limit of participants in this research project?
"Affirmative. Clinicaltrials.gov shows that this research is presently enrolling patients, first posted on January 16th 2018 and last amended July 13th 2022. This study needs to recruit 4000 people at a single location." - Anonymous Online Contributor
Is this medical experiment actively enrolling participants?
"Affirmative. Records on clinicaltrials.gov declare that this medical trial, which was first posted on January 16th 2018, is actively recruiting participants at the moment. It aims to enroll up to 4000 patients from a single location." - Anonymous Online Contributor